Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (131-140 of 560) with videos related to

Pageof 56
Sort By:
Cancers|November 13, 2025
Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future PerspectivesPierre-Etienne Gabriel, Amir Horowitz, Felix Guerrero-Ramos, et al.
Arab Journal of Urology|October 8, 2020
The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic reviewRoberto Carando, Luca Afferi, Giancarlo Marra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 19, 2015
Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancerMarco Moschini, Giorgio Gandaglia, Nazareno Suardi, et al.
Anticancer Research|June 13, 2014
Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinomaMarco Moschini, Nazareno Suardi, Federico Pellucchi, et al.
Minerva Urology and Nephrology|March 31, 2023
Comment on: "Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry"Vincenzo Asero, Wojciech Krajewski, Benjamin Pradere, et al.
European Urology|February 18, 2026
Corrigendum to "Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials" [Eur. Urol. (2025)]Pietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
The Prostate|July 17, 2015
Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selectionGiorgio Gandaglia, Jonas Schiffmann, Thorsten Schlomm, et al.
Urologic Oncology|August 16, 2022
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping reviewTiago Costa de Padua, Marco Moschini, Alberto Martini, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 17, 2021
Single staff cystectomy in a low-volume center: Oncological outcomes and complicationsPhilipp Baumeister, Davide Galioto, Marco Moschini, et al.
European Urology|January 1, 2026
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC TrialsPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Pageof 56

Showing results (131-140 of 560) with videos related to

Sort By:
Pageof 56
Cancers|November 13, 2025
Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future PerspectivesPierre-Etienne Gabriel, Amir Horowitz, Felix Guerrero-Ramos, et al.
Arab Journal of Urology|October 8, 2020
The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic reviewRoberto Carando, Luca Afferi, Giancarlo Marra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 19, 2015
Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancerMarco Moschini, Giorgio Gandaglia, Nazareno Suardi, et al.
Anticancer Research|June 13, 2014
Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinomaMarco Moschini, Nazareno Suardi, Federico Pellucchi, et al.
Minerva Urology and Nephrology|March 31, 2023
Comment on: "Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry"Vincenzo Asero, Wojciech Krajewski, Benjamin Pradere, et al.
European Urology|February 18, 2026
Corrigendum to "Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials" [Eur. Urol. (2025)]Pietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
The Prostate|July 17, 2015
Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selectionGiorgio Gandaglia, Jonas Schiffmann, Thorsten Schlomm, et al.
Urologic Oncology|August 16, 2022
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping reviewTiago Costa de Padua, Marco Moschini, Alberto Martini, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 17, 2021
Single staff cystectomy in a low-volume center: Oncological outcomes and complicationsPhilipp Baumeister, Davide Galioto, Marco Moschini, et al.
European Urology|January 1, 2026
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC TrialsPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Pageof 56